BIT Computer Co., Ltd (KOSDAQ:032850)
5,110.00
+210.00 (4.29%)
Feb 3, 2026, 2:19 PM KST
BIT Computer Revenue
BIT Computer had revenue of 8.45B KRW in the quarter ending September 30, 2025, with 0.21% growth. This brings the company's revenue in the last twelve months to 35.63B, down -2.93% year-over-year. In the year 2024, BIT Computer had annual revenue of 37.07B with 10.81% growth.
Revenue (ttm)
35.63B
Revenue Growth
-2.93%
P/S Ratio
2.16
Revenue / Employee
274.05M
Employees
130
Market Cap
76.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 37.07B | 3.62B | 10.81% |
| Dec 31, 2023 | 33.46B | -1.68B | -4.77% |
| Dec 31, 2022 | 35.13B | -1.30B | -3.56% |
| Dec 31, 2021 | 36.43B | -1.58B | -4.15% |
| Dec 31, 2020 | 38.01B | 633.84M | 1.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4.56T |
| Celltrion | 3.90T |
| Sam Chun Dang Pharm. | 220.74B |
| ALTEOGEN | 202.18B |
| Kukje Pharma | 173.80B |
| PharmGen Science | 171.66B |
| Yuyu Pharma | 139.51B |
| Ray Co., Ltd. | 97.57B |